Ketamine was first synthesized in 1962 as a derivative of phencyclidine and quickly became adopted in both veterinary and human medicine. The drug functions as an N-methyl-D-aspartate (NMDA) receptor antagonist rather than targeting GABA receptors like conventional anesthetics. This mechanism supports pain relief and dissociative sedation without the degree of respiratory and cardiovascular depression typical of other agents. Ketamine's stimulation of the sympathetic nervous system helps preserve hemodynamic stability through increased cardiac output and blood pressure, which is particularly beneficial in critically ill pediatric patients.
Ketamine demonstrates significant safety advantages, especially in resource-limited environments. It maintains airway reflexes and spontaneous breathing while reducing respiratory depression risk, making it valuable when advanced airway management resources may not be immediately available. Research has shown that combining ketamine with propofol enhances anesthetic efficacy and reduces side effects such as postoperative nausea and respiratory complications compared to ketamine alone, resulting in smoother recovery for pediatric patients.
Beyond surgical anesthesia, ketamine serves procedural sedation for diagnostic imaging and minor procedures due to its rapid onset and short duration. In pediatric emergency medicine, it is particularly effective for treating severe asthma through bronchodilation without cardiovascular suppression, making it a valuable tool for respiratory stabilization in urgent situations.
Challenges include emergence reactions such as hallucinations and dysphoria in some younger patients. Co-administration of midazolam has been shown to reduce these adverse effects and improve recovery comfort for children, and is now a common part of ketamine-based anesthetic protocols in pediatric practice.
Ongoing research continues to explore additional therapeutic applications of ketamine, including its anti-inflammatory and neuroprotective properties in acute conditions and neurodevelopmental disorders. Ketamine's combination of bronchodilatory properties, hemodynamic preservation, and airway reflex maintenance highlights its continued versatility in pediatric anesthesia care.